SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

73,353.72 -253.03
( -0.34%)

Global Indices

Nasdaq

52,379.88 143.72
(0.28%)

Dow Jones

7,698.05 53.37
(0.70%)

Hang Seng

62,433.43 -259.73
(-0.41%)

Nikkei 225

10,766.40 76.04
(0.71%)

Forex

USD-INR

94.61 0.10
(0.11%)

EUR-INR

106.18 0.08
(0.07%)

GBP-INR

126.70 0.19
(0.15%)

JPY-INR

0.60 0.00
(0.70%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Vivimed Labs Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

532660

INE526G01021

-18.1148384

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

VIVIMEDLAB

49.5

EPS(TTM)

Face Value()

Div & Yield %

Back

Artson reports standalone net loss of Rs 0.41 crore in the June 2026 quarter

Jul 16,2026

Net loss of Artson reported to Rs 0.41 crore in the quarter ended June 2026 as against net profit of Rs 0.22 crore during the previous quarter ended June 2025. Sales declined 41.60% to Rs 26.13 crore in the quarter ended June 2026 as against Rs 44.74 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	26.13	44.74	-42
OPM %	4.55	7.47	-
PBDT	-0.15	1.04	PL
PBT	-0.77	0.47	PL
NP	-0.41	0.22	PL

73,353.72 -253.03 ( -0.34%)

52,379.88 143.72 (0.28%)

7,698.05 53.37 (0.70%)

62,433.43 -259.73 (-0.41%)

10,766.40 76.04 (0.71%)

94.61 0.10 (0.11%)

106.18 0.08 (0.07%)

126.70 0.19 (0.15%)

0.60 0.00 (0.70%)